Pages that link to "Q34146989"

The following pages link to Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury (Q34146989):

Displaying 46 items.

• Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia (Q26849333) (← links)
• To drive or be driven: the path of a mouse model of recurrent pregnancy loss (Q26866038) (← links)
• Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment (Q26999710) (← links)
• The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies (Q33397768) (← links)
• The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia (Q33668328) (← links)
• A new mouse model to explore therapies for preeclampsia (Q33737551) (← links)
• Reduced stathmin-1 expression in natural killer cells associated with spontaneous abortion (Q33808043) (← links)
• At Term, XmO and XpO Mouse Placentas Show Differences in Glucose Metabolism in the Trophectoderm-Derived Outer Zone (Q33819228) (← links)
• Tim-3 and PD-1 regulate CD8+ T cell function to maintain early pregnancy in mice (Q33826692) (← links)
• Synthetic PreImplantation Factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response. (Q33898461) (← links)
• Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity (Q34056273) (← links)
• New therapeutic targets for the antiphospholipid syndrome (Q34140319) (← links)
• In vitro assessment of mouse fetal abdominal aortic vascular function (Q34201168) (← links)
• Repeated abortion affects subsequent pregnancy outcomes in BALB/c mice (Q34465012) (← links)
• Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients (Q34494348) (← links)
• Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model (Q34533751) (← links)
• Statin use during pregnancy: a systematic review and meta-analysis (Q34636432) (← links)
• The fetal safety of statins: a systematic review and meta-analysis. (Q34662447) (← links)
• Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside (Q34994012) (← links)
• Plasma MIC-1 and PAPP-a levels are decreased among women presenting to an early pregnancy assessment unit, have fetal viability confirmed but later miscarry (Q34998473) (← links)
• Tissue factor, blood coagulation, and beyond: an overview (Q35222618) (← links)
• Heme oxygenase and the immune system in normal and pathological pregnancies (Q35535112) (← links)
• Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5. (Q36205244) (← links)
• Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). (Q36455584) (← links)
• Neutrophil migration into the placenta: Good, bad or deadly? (Q36857949) (← links)
• Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF. (Q37409590) (← links)
• Role of tissue factor in feto‐maternal development: a xiphos (Q37808760) (← links)
• Potential use of statins in the treatment of antiphospholipid syndrome. (Q37959316) (← links)
• Complement in pregnancy: a delicate balance (Q38038295) (← links)
• Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? (Q38193203) (← links)
• Hypertension in pregnancy: natural history and treatment options (Q38400715) (← links)
• Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt (Q38987120) (← links)
• MicroRNA-20b and ERK1/2 pathway independently regulate the expression of tissue factor in hematopoietic and trophoblastic differentiation of human embryonic stem cells (Q39036023) (← links)
• Impact of haemostatic mechanisms on pathophysiology of preeclampsia (Q39163214) (← links)
• Serum levels of TNF-alpha and antioxidant enzymes and placental TNF-alpha expression in unexplained recurrent spontaneous miscarriage (Q46170723) (← links)
• Targeted inhibition of complement activation prevents features of preeclampsia in mice (Q46329692) (← links)
• Infection of pregnant mice with Listeria monocytogenes induces fetal bradycardia (Q46426910) (← links)
• The Complement System and Preeclampsia (Q47889401) (← links)
• Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. (Q53279655) (← links)
• Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models (Q57470987) (← links)
• Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide (Q57714214) (← links)
• Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation (Q61415568) (← links)
• Silica and titanium dioxide nanoparticles cause pregnancy complications in mice (Q83772051) (← links)
• Elevated lipoprotein(a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR) (Q86494328) (← links)
• Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect (Q89026308) (← links)
• Genetics of recurrent pregnancy loss among Iranian population (Q92304516) (← links)